Filing Flows › Endovia Health Sciences (EDVA) › Q1 2025 › vs Q1 2024
Endovia Health Sciences (EDVA) Q1 2025 vs Q1 2024 (year over year)
Endovia Health Sciences's revenue fell $1.1M (-72%) from $1.5M in Q1 2024 to $438K in Q1 2025.
Endovia Health Sciences, Q1 2025: revenue $438K (-72% year over year), operating margin -463.8%, net loss $3.7M, operating cash flow −$724K. The chart draws each line against Q1 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q1 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $438K | $1.5M | −$1.1M | -72% |
| Net loss | $3.7M | $4.7M | −$1.0M | -22% |
| Costs & expenses | $4.1M | $6.2M | −$2.1M | -34% |
| Operating costs | $2.5M | $4.8M | −$2.3M | -48% |
| Interest & other, net | $1.6M | $1.4M | $197K | +14% |
| Sales & marketing | $43K | $202K | −$159K | -79% |
| Other operating costs | $2.0M | $3.2M | −$1.3M | -39% |
| Operating cash sources | $3.7M | $4.7M | −$1.0M | -22% |
| Depreciation | $37K | $135K | −$98K | -73% |
| Share-based compensation | $141K | $557K | −$416K | -75% |
| Working capital & other | $2.7M | $2.7M | $78K | +3% |
| Cash used in operations | $724K | $1.3M | −$584K | -45% |
| Net loss absorbed | $3.7M | $4.7M | −$1.0M | -22% |
Questions
How much did Endovia Health Sciences's revenue grow year over year in Q1 2025?
Endovia Health Sciences's revenue fell $1.1M (-72%) from $1.5M in Q1 2024 to $438K in Q1 2025.